Structure-transport relationship for the intestinal small-peptide carrier: Is the carbonyl group of the peptide bond relevant for transport?

Pharmaceutical Research

Volumn 16, Issue 1, 1999, Pages 62-68

  Schoenmakers, Ronald G ^a   Stehouwer, Marco C ^a   Tukker, Josef J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Enalapril; Intestinal small peptide carrier; Peptide bond; Structure transport relation

Indexed keywords

AMOXICILLIN; CARBONYL DERIVATIVE; CEFALEXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; ENAMIPRIL; GLYCOPROTEIN P; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ILEUM MUCOSA; INTESTINE MUCOSA; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; RAT;

AMOXICILLIN; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BIOLOGICAL TRANSPORT; CARBON; CARRIER PROTEINS; ENALAPRIL; INTESTINES; MALE; MODELS, MOLECULAR; OXYGEN; PEPTIDES; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032930327     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018866611555     Document Type: Article

References (22)

1. A. Tsuji and I. Tamai. Carrier-mediated intestinal transport of drugs. Pharm. Res. 13:963-977 (1996).
2. V. Ganapathy and F. H. Liebach. Is intestinal peptide transport energized by a proton gradient? Am. J. Physiol. 249:G153-G160 (1985).
3. + coupled uphill transport of aminocephalosporins via the dipeptide transport system in rabbit intestinal brush-border membranes. J. Biol. Chem. 261:14130-14134 (1986).
4. P. J. Sinko and G. L. Amidon. Characterization of the oral absorption of β-lactam antibiotics. I. Cephalosporins: determination of intrinsic membrane absorption parameters in the rat intestine in situ. Pharm. Res. 5:645-650 (1988).
5. A. Tsuji, E. Nakashima, I. Kagami, and T. Yamana. Intestinal absorption mechanism of amphoteric β-lactam antibiotics I: comparative absorption and evidence for saturable transport of amino-β-lactam antibiotics by in situ rat small intestine. J. Pharm. Sci. 70:768-772 (1981).
6. M. Hu and G. L. Amidon. Passive and carrier-mediated intestinal absorption components of captopril. J. Pharm. Sci. 77:1007-1011 (1988).
7. D. J. Friedman and G. L. Amidon. Passive and carrier-mediated intestinal absorption components of two angiotensin-converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril. Pharm. Res. 6:1043-1047 (1989).
8. S. Chulavatnatol and B. Charles. Antagonism of sodium amoxycillin absorption in man following oral administration with glycylpeptides. Eur. J. Pharm. Biopharm. 40:374-378 (1994).
9. Y. Fei, Y. Kanai, S. Nussberger, V. Ganapathy, and F. H. Leibach. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 368:563-566 (1994).
10. P. F. Bai, P. Subramanian, H. I. Mosberg, and G. L. Amidon. Structural requirements for the intestinal mucosal-cell peptide transporter: The need for N-terminal. Pharm. Res. 8:593-599 (1991).
11. P. W. Swaan and J. J. Tukker. Molecular determinants of recognition for the intestinal peptide carrier. J. Pharm. Sci. 86:596-602 (1997).
12. P. W. Swaan, M. C. Stehouwer, and J. J. Tukker. Molecular mechanism for the relative affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril. Biochem. Biophys. Acta 1236:31-38 (1995).
13. M. Enjoh, K. Hashimoto, S. Arai, and M. Shimizu. Inhibitory effect of arphamenine A on intestinal dipeptide transport. Biosci. Biotech. Biochem. 60:1893-1895 (1996).
14. C. S. Temple, A. K. Stewart, D. Meredith, N. A. Lister, K. M. Morgan, I. D. Collier, R. D. Vaughan-Jones, C. A. R. Boyd, P. D. Bailey, and J. R. Bronk. Peptide mimics as substrate for the intestinal peptide transporter. J. Biol. Chem. 273:20-22 (1998).
15. H. H. Ussing and K. Zehran. Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. Acta Physiol. Scand. 23:110-127 (1951).
16. T. Tsuruo, H. Iida, S. Tsukagoshi, and Y. Sakurai. Overcoming of vincrastine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincrastine and vinblastine by verapamil. Cancer Res. 41:1967-1972 (1981).
17. European Pharmacopoeia, third edition. Council of Europe, Strassbourg, 1996.
18. S. A. Ranadive, A. X. Chen, and A. T. M. Serajuddin. Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors. Pharm. Res. 9:1480-1486 (1992).
19. D. P. Ip and G. S. Brenner. Enalapril maleate. In K. Florey (ed.), Analytical profiles of drug substances. Vol. 16, Academic Press Inc. New York, 1987, pp. 207-243.
20. M. E. Ganapathy, W. Huang, H. Wang, V. Ganapathy, and F. H. Leibach. Valacyclovir: a substrate for the intestinal and renal peptide transporters PepT1 and PepT2. Biochem. Biophys. Res. Commun. 246:470-475 (1998).
21. P. S. Burton, R. A. Conradi, A. R. Hilgers, and N. F. H. Ho. Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. Biochem. Biophys. Res. Commun. 190:760-766 (1993).
22. Y. Emi, D. Tsunashima, K.-I. Ogawara, K. Higaki, and T. Kimura. Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine. J. Pharm. Sci. 87:295-299 (1997).